IL4 and cancer: In addition, the involvement of certain interleukins including IL-6, IL-4, IL-17A and IL-32β in some EMT pathways signifies their specific contribution in metastastic processes, thereby warranting further work into the development of diagnostic and immunotherapeutic tools in cancer.